Ambu A/S Lowers Sales Forecast as Shares Plunge 18%

Medical equipment manufacturer Ambu A/S lowered its full-year organic sales forecast to 10%, down from a previous range of 10-12%. This second guidance cut of the year was primarily driven by lower sales expectations for the company's legacy business of breathing bags and resuscitation dummies.

The announcement caused shares to drop as much as 18%. The decline revived investor anxiety regarding a previous period of serial profit warnings under former CEO Juan-Jose Gonzalez, who was dismissed after slashing growth outlooks seven times during a three-year tenure.

Chief Executive Officer Britt Meelby Jensen defended the company's trajectory, stating that Ambu is a different business today and remains on track to meet long-term targets. This includes an annual organic revenue growth goal of 11-13% by fiscal 2029/30. Jensen specifically maintained the growth forecast for the single-use endoscope division, identifying the industry shift away from reusable products as a primary driver for future expansion.